ES2099247T3 - Iloprost con efecto contra la malaria cerebral. - Google Patents
Iloprost con efecto contra la malaria cerebral.Info
- Publication number
- ES2099247T3 ES2099247T3 ES92904592T ES92904592T ES2099247T3 ES 2099247 T3 ES2099247 T3 ES 2099247T3 ES 92904592 T ES92904592 T ES 92904592T ES 92904592 T ES92904592 T ES 92904592T ES 2099247 T3 ES2099247 T3 ES 2099247T3
- Authority
- ES
- Spain
- Prior art keywords
- iloprost
- effect against
- against brain
- brain malaria
- pct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 title abstract 2
- 229960002240 iloprost Drugs 0.000 title abstract 2
- 210000004556 brain Anatomy 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 206010063094 Cerebral malaria Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4104606A DE4104606C1 (enExample) | 1991-02-12 | 1991-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2099247T3 true ES2099247T3 (es) | 1997-05-16 |
Family
ID=6425074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92904592T Expired - Lifetime ES2099247T3 (es) | 1991-02-12 | 1992-02-07 | Iloprost con efecto contra la malaria cerebral. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5466713A (enExample) |
| EP (1) | EP0571457B1 (enExample) |
| JP (1) | JP3322311B2 (enExample) |
| KR (1) | KR100188164B1 (enExample) |
| AT (1) | ATE147628T1 (enExample) |
| AU (1) | AU663484B2 (enExample) |
| CA (1) | CA2103906C (enExample) |
| DE (2) | DE4104606C1 (enExample) |
| DK (1) | DK0571457T3 (enExample) |
| ES (1) | ES2099247T3 (enExample) |
| GR (1) | GR3022870T3 (enExample) |
| WO (1) | WO1992013537A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4124695C2 (de) * | 1991-07-22 | 1994-12-22 | Blitstein Willinger Eveline Dr | Verwendung von Carbacyclinderivaten zur Behandlung von Psoriasis vulgaris |
| DE4226615C1 (de) * | 1992-08-07 | 1994-05-19 | Schering Ag | Verwendung von Prostan-Derivaten zur Behandlung von chronischer Polyarthritis |
| WO2004071508A1 (en) * | 2003-02-14 | 2004-08-26 | Medical Research Council | Ip receptor antagonists for the treatment of pathological uterine conditions |
| CN102697790A (zh) | 2003-05-22 | 2012-10-03 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| US8747897B2 (en) | 2006-04-27 | 2014-06-10 | Supernus Pharmaceuticals, Inc. | Osmotic drug delivery system |
| WO2009078965A1 (en) | 2007-12-17 | 2009-06-25 | United Therapeutics Corporation | An improved process to prepare treprostinil, the active ingredient in remodulin |
| CA2862544A1 (en) * | 2012-02-02 | 2013-08-08 | Randal Alan Hoke | Sample collection devices with blood stabilizing agents |
| WO2014159050A1 (en) | 2013-03-14 | 2014-10-02 | United Therapeutics Corporation | Solid forms of treprostinil |
| CN107108427A (zh) | 2014-10-20 | 2017-08-29 | 联合治疗学有限公司 | 用于制备前列环素衍生物的中间体的合成 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2845770A1 (de) * | 1978-10-19 | 1980-04-30 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| DE3121155A1 (de) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
-
1991
- 1991-02-12 DE DE4104606A patent/DE4104606C1/de not_active Expired - Lifetime
-
1992
- 1992-02-07 EP EP92904592A patent/EP0571457B1/de not_active Expired - Lifetime
- 1992-02-07 CA CA002103906A patent/CA2103906C/en not_active Expired - Fee Related
- 1992-02-07 DK DK92904592.0T patent/DK0571457T3/da active
- 1992-02-07 AU AU12375/92A patent/AU663484B2/en not_active Ceased
- 1992-02-07 WO PCT/DE1992/000091 patent/WO1992013537A1/de not_active Ceased
- 1992-02-07 DE DE59207900T patent/DE59207900D1/de not_active Expired - Lifetime
- 1992-02-07 AT AT92904592T patent/ATE147628T1/de not_active IP Right Cessation
- 1992-02-07 ES ES92904592T patent/ES2099247T3/es not_active Expired - Lifetime
- 1992-02-07 JP JP50411992A patent/JP3322311B2/ja not_active Expired - Fee Related
- 1992-02-07 US US08/104,068 patent/US5466713A/en not_active Expired - Fee Related
-
1993
- 1993-08-11 KR KR1019930702385A patent/KR100188164B1/ko not_active Expired - Fee Related
-
1997
- 1997-03-18 GR GR970400545T patent/GR3022870T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE59207900D1 (de) | 1997-02-27 |
| CA2103906C (en) | 2003-06-03 |
| ATE147628T1 (de) | 1997-02-15 |
| US5466713A (en) | 1995-11-14 |
| WO1992013537A1 (de) | 1992-08-20 |
| JP3322311B2 (ja) | 2002-09-09 |
| AU663484B2 (en) | 1995-10-12 |
| AU1237592A (en) | 1992-09-07 |
| EP0571457A1 (de) | 1993-12-01 |
| JPH06507380A (ja) | 1994-08-25 |
| DK0571457T3 (da) | 1997-07-14 |
| KR100188164B1 (en) | 1999-06-01 |
| DE4104606C1 (enExample) | 1992-10-15 |
| GR3022870T3 (en) | 1997-06-30 |
| CA2103906A1 (en) | 1992-08-13 |
| EP0571457B1 (de) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN172468B (enExample) | ||
| BG104247A (bg) | Производни на резорцинола | |
| DE68929540T2 (de) | Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen | |
| DE69111077D1 (de) | Chinazolinderivate um die antitumorwirkung zu verbessern. | |
| UA27911C2 (uk) | Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну | |
| ATE368660T1 (de) | Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside | |
| HU912272D0 (en) | Process for the production of 2,6-dialkyl-4- silil-phenol derivatives | |
| HUT44472A (en) | Process for production of derivatives of /phenil or alkyl-oxo/-phenol with lenhotrien antagonistic effect | |
| YU48666B (sh) | Mometason furoat monohidrat i postupak za njegovo dobijanje | |
| MY107573A (en) | 2,4- and 2, 5-substituted pyridine-n-oxides, processes for their preparation and their use. | |
| DK0571457T3 (da) | Iloprost med virkning overfor cerebral malaria. | |
| IT8320435A0 (it) | Composizione per il trattamento dell'acne. | |
| AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
| ES2079872T3 (es) | Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina. | |
| GR3017358T3 (en) | 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants. | |
| TR200003203T2 (tr) | Karboksaldehitin saflaştırılması | |
| FI921474A0 (fi) | Antimetastatiskt fungerande aemnen. | |
| WO1992010473A3 (en) | 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives | |
| MX9602767A (es) | Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina. | |
| ES1018239Y (es) | Ensamblador para la fabricacion de marcos. | |
| IT1228930B (it) | Diclorotrifluorometilnitrotolueni e loro conversione in aminotrifluorometiltolueni | |
| UA41496A1 (uk) | Спосіб кування злитку |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 571457 Country of ref document: ES |